| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |